Clinical Trials Update: Feb. 9, 2011
Stage 2 Diastolic Hypertension Hot Flashes High Cholesterol
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Stage 2 Diastolic Hypertension
This study will evaluate the safety and effectiveness of a two-pill combination of nebivolol and lisinopril in people with stage 2 diastolic hypertension.
The research site is in Burbank, Calif.
This study will evaluate an investigational non-hormonal drug to treat hot flashes. Candidates must be 40 or older, post menopausal, and have seven-to-eight moderate-to-severe hot flashes in a 24-hour period.
The research site is in Katy, Texas.
This study will evaluate various lipid-lowering agents in people at high cardiac risk whose cholesterol is not well controlled with Lipitor 10 mg. Candidates must be aged 18 to 80 and be diabetic or have history of heart problems.
The research site is in Pinellas Park, Fla.
Copyright 2011 ClinicalConnection.com. All rights reserved.